InvestorsHub Logo
Followers 7
Posts 591
Boards Moderated 0
Alias Born 04/18/2005

Re: A deleted message

Friday, 09/01/2017 10:29:36 AM

Friday, September 01, 2017 10:29:36 AM

Post# of 346390
+++Phase II Bavi+Docetaxel vs. Adv./Met. Breast Cancer in E.EUR/GA (Refractory):

Reported in the 8-24-11 PR

MOS=20.7mos. (ORR), was 61%, with 11% of the patients achieving a clinical complete response

Phase II Bavi+CP vs. Adv./Met. Breast Cancer in INDIA (Front-Line):

PR 11-22-11:

MOS=23.2mos. has been reached in Peregrine’s Bavi+carboplatin and paclitaxel/FrontLineMBC

Golfho...

If I remember correctly, King cried poverty and proclaimed that the breast cancer field was just "too crowded".

Another brilliant leadership blunder. They had their opportunity to partner it right then and balked. Assuming there was no outside interest at the time is merely 420 talk.

+++It’s still early in the game, there’s still a lot more to come before we shareholders need to decide.

I just don't see it. Maybe there is a miracle surprise in store...but it would be just that....a borderline miracle.

The "PAIN-O-METER" I referred to in a post a while back is definitely on 10 now regarding the share price and lack of support. No surprise.

Ronin will salvage this disaster...and right now it is just that...a management created disaster.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News